share_log

8-K: Current report

8-K: Current report

8-K:重大事件
美股SEC公告 ·  09/10 06:04

Moomoo AI 已提取核心信息

On September 9, 2024, Cingulate Inc., a company listed on the Nasdaq Stock Market, announced that it has regained compliance with the Nasdaq's Minimum Bid Price requirement. The Nasdaq Hearings Panel confirmed that Cingulate's common stock met the $1.00 minimum bid price condition necessary for continued listing on the exchange. This follows a previous notification on June 17, 2024, when Cingulate was informed of its non-compliance with the same requirement. The company was granted an exception on August 2, 2024, to meet this requirement by August 23, 2024. Despite regaining compliance, Cingulate will remain under the Nasdaq Panel's discretionary monitoring until May 21, 2025, to ensure ongoing adherence to the exchange's listing rules.
On September 9, 2024, Cingulate Inc., a company listed on the Nasdaq Stock Market, announced that it has regained compliance with the Nasdaq's Minimum Bid Price requirement. The Nasdaq Hearings Panel confirmed that Cingulate's common stock met the $1.00 minimum bid price condition necessary for continued listing on the exchange. This follows a previous notification on June 17, 2024, when Cingulate was informed of its non-compliance with the same requirement. The company was granted an exception on August 2, 2024, to meet this requirement by August 23, 2024. Despite regaining compliance, Cingulate will remain under the Nasdaq Panel's discretionary monitoring until May 21, 2025, to ensure ongoing adherence to the exchange's listing rules.
2024年9月9日,纳斯达克股票市场上市公司Cingulate Inc.宣布其已恢复纳斯达克的最低买盘价格要求。纳斯达克听证会确认Cingulate的普通股票满足交易所继续上市所必需的1.00美元的最低买盘价格条件。这是继2024年6月17日之前一次通知Cingulate其不符合同一要求后的消息。公司于2024年8月2日获准在2024年8月23日前满足该要求的特例。尽管恢复了符合性,但Cingulate将在2025年5月21日之前继续处于纳斯达克听证会的自由检查之下,以确保持续遵守交易所的上市规则。
2024年9月9日,纳斯达克股票市场上市公司Cingulate Inc.宣布其已恢复纳斯达克的最低买盘价格要求。纳斯达克听证会确认Cingulate的普通股票满足交易所继续上市所必需的1.00美元的最低买盘价格条件。这是继2024年6月17日之前一次通知Cingulate其不符合同一要求后的消息。公司于2024年8月2日获准在2024年8月23日前满足该要求的特例。尽管恢复了符合性,但Cingulate将在2025年5月21日之前继续处于纳斯达克听证会的自由检查之下,以确保持续遵守交易所的上市规则。
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息